Showing results (91-100 of 459) with videos related to
Sort By:
Pageof 46
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1989
Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychoticsG A Gudelsky, H Y MeltzerAmerican Journal of Clinical Pathology|January 1, 1979
Factors affecting stability of isozymes of creatine phosphokinaseH W Cho, H Y MeltzerBiological Psychiatry|May 1, 1988
Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysisJ L Zureick, H Y MeltzerArchives of General Psychiatry|June 1, 1976
Serum creatine phosphokinase activity in psychiatrically hospitalized childrenJ W Crayton, H Y MeltzerThe Journal of Clinical Psychiatry|May 16, 2000
Adverse events related to olanzapineR R Conley, H Y MeltzerThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1992
The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivoB K Yamamoto, H Y MeltzerThe Journal of Clinical Psychiatry|September 1, 1994
The pharmacoeconomics of clozapine: a reviewH Y Meltzer, P A ColaPsychiatry Research|October 1, 1983
A blind, controlled study of occipital cerebral asymmetry in schizophreniaD J Luchins, H Y MeltzerSchizophrenia Bulletin|January 1, 1980
Factors affecting determination of platelet monoamine oxidase activityH L Jackman, H Y MeltzerLife Sciences|January 1, 1989
Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patientsR C Arora, H Y MeltzerPageof 46